Around the year 1990, it was discovered that src-homology 2 (SH2) domains could bind to phosphotyrosine Margolis et al., 1990; Mayer and Hanafusa, 1990; Moran et al., 1990) . A number of proteins implicated in protein-tyrosine kinase signaling pathways were known to contain SH2 domains, and this discovery revealed how these proteins could form multimeric signaling complexes in response to activation of growth factor receptor family protein-Tyr kinases. However, this discovery also raised the question of how distinct growth factor receptors recruited different subsets of SH2-containing signaling proteins.
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At about the same time, we had noticed that a tyrosine phosphorylation site in polyoma middle t (Tyr-315: TyrMet-Pro-Met) that was involved in binding to the p85 regulatory subunit of phosphoinositide 3-kinase (PI3K) shared a short sequence motif with two sites in the PDGF receptor (Tyr-740: Tyr-Met-Asp-Met and Tyr-751 : Tyr-VaI-Pro-Met) that had also been recently implicated in binding PI3K (Cantley et al., 1991) . Also of importance was the discovery that other SH2-containing proteins appeared to bind at distinct sites on this protein, raising the possibility that the SH2 domains of p85 not only bound phosphotyrosine, but also recognized a unique sequence context immediately C-terminal of the phosphotyrosine to insure that PI3K is recruited to only a subset of tyrosine-phosphorylated sites. The implication was that other SH2 domains might select for distinct motifs, thereby providing a zip code for insuring selectivity in SH2 domain-mediated recruitment of downstream signaling proteins.
The idea of a unique sequence motif zip code for designating binding to each SH2 domain was attractive, but to tease out the rules for this selection and identify the optimal motif for every SH2 domain was a daunting task. With existing technology, it would have required synthesis of millions or even billions of individual phosphopeptides and performing binding experiments one at a time to be certain of the optimal motif. In 1990, the synthesis of phosphopeptides was novel and expensive, and large-scale arraying of peptides had not been developed. We were extremely lucky to work with Steven Shoelson (Harvard Medical School) and Michael Berne (Tufts University), two experts in synthesizing phosphotyrosine-containing peptides and peptide mixture libraries.
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We realized that although it was expensive to make and purify individual phosphopeptides, it was relatively cheap to make mixtures of phosphopeptides by adding an isokinetic mixture of all 20 amino acids at each round of synthesis using a commercial peptide synthesizer. The price of making such a library was only slightly more than making a single peptide. The question was whether a given SH2 domain could selectively extract, from a degenerate mixture of phosphotyrosine-containing peptides, sufficient quantities of high-affinity peptides to allow identification. To test this idea, we first synthesized a small mixture of phospho-Tyr peptides based on the sequence around Tyr-315 of polyoma middle t, but with all 20 amino acids rather than just Met at the +3 position (e.g., phosphoTyr-Met-Pro-Xxx). This mixture was passed over a column containing the N-terminal SH2 domain of the p85 subunit of PI3K. The peptide mixture that was retained on the column was added directly to an Edman sequencer, rather than being separated first into individual pure peptides. We reasoned that since all peptides in the mixture were the same length and had phosphotyrosine at the same position, the relative abundance of the 20 amino acids at the position of degeneracy would reveal the relative retention of the 20 peptides. As further controls, we compared this sequence with the sequence of the starting mixture and with the sequence of the flowthrough. To our delight, the sequence of the retained peptide mixture revealed almost exclusively Met at the +3 position, indicating, as we had suspected, that the p85 SH2 domain preferred to bind sites with Met at the +3 position.
This success gave us the courage to apply this approach to more degenerate mixtures. We synthesized a mixture in which 18 amino acids (omitting Trp and Cys) were varied at the three positions C-terminal of phosphoTyr (Gly-Asp-Gly-phosphoTyr-Xxx-Xxx-XxxSer-Pro-Leu-Leu-Leu) and repeated the same experiment with this "library." Again, rather than attempt to separate the 5832 possible peptides retained and determine their relative abundance, we sequenced the mixture as a batch on an Edman sequencer. The fact that all peptides in the library were "oriented" by phosphotyrosine at the fourth residue insured that all the peptides would be in phase during sequencing. Thus, during Edman sequencing of the mixture, cycle 5 from the Edman sequencer was the phosphoTyr +1 position in all peptides (the first position of degeneracy) and thus would likely interact with the same region of the SH2 domain.
The results once again revealed that the subset of peptides that were preferentially retained almost all had Met at the +3 position. In addition, we found that peptides with Met, lie, or Val at the +1 position were preferentially retained but that there was no enrichment for particular amino acids in the +2 position in the subset of preferentially retained peptides. These results were in good agreement with sites on proteins where p85 binding was implicated,
Since we did not compare the affinity of individual peptides but rather deduced the commonly selected amino acids at specific positions relative to phosphoty-rosine in the retained peptides, the implicit assumption was that one could obtain useful information about the selectivity of a peptide binding domain by evaluating each position of the set of high-affinity peptides individually in the background of degeneracy at surrounding positions. While this simplifying assumption was likely to miss some nearest neighbor effects, the consistency of the results with in vivo p85 binding sites argued for the value of the approach. Importantly, since the approach could be expanded to even higher levels of degeneracy (eventually to libraries containing billions of peptides), did not require foreknowledge of SH2 domain binding partners, and could be performed in one day, we realized that it was feasible to determine the binding motifs of all SH2 domains in a relatively short time.
Thanks to many people in the field, we were able to quickly obtain a large number of SH2 domain constructs and examine their specificity using this approach. The results from analyses of over 30 SH2 domains not only supported our hypothesis that SH2 domains recognize specific sequences surrounding the phosphotyrosine, but also showed that this information was useful in predicting binding partners for individual SH2 domains based on primary sequences of proteins (Songyang et al., 1993 . For example, we found that the optimal motif for binding to the Src SH2 domain was phosphoTyr-Glu-Glu-Ile, a sequence found on polyoma middle T antigen.
Before the specificities of SH2 domains were investigated systematically, the in vivo targets of SH2 domain proteins had been largely unknown. Even in cases where receptor tyrosine kinases were found to bind SH2 domain-containing proteins, the exact binding sites of the SH2 domains often remained ambiguous. The SH2 domain specificity information gathered from our oriented peptide library studies have since helped many laboratories to map the in vivo binding sites of their favorite SH2 domains. In the following years, numerous publications reported the identification of specific tyrosine sequences recognized by different SH2 domains. As a result, our original and subsequent follow-up studies on SH2 domain specificities were among the most frequently referenced publications in the field in the mid 1990s.
The identification of optimal phosphotyrosine peptides for individual SH2 domains also facilitated understanding of the structural basis for SH2 domain specificity. At the same time that we were determining the specificity of SH2 domains, John Kuriyan's laboratory published the structure of the Src SH2 domain bound to a peptide from the C-terminal tail of c-Src containing phosphoTyr-527 (Waksman et al., 1992) . However, it was difficult to tell from the structure how the specificity of SH2 domains was determined, since the peptide was of low affinity and revealed minimal contact outside the phosphoTyr binding pocket. In the meantime, Stephen Harrison's laboratory was crystallizing the SH2 domain of the src family member Lck. Both groups were excited about our findings and went on to cocrystalize these two SH2 domains with the high-affinity phosphoTyr-GluGlu-Ile peptide (Eck et al., 1993; Waksman et al., 1993) . These crystal structures provided a clear explanation for the selection of acidic residues at the +1 and +2 positions and revealed a hydrophobic pocket for lie at the +3 position.
Based on the cocrystals of the src and Ick SH2 domains with the phosphoTyr-Glu-Glu-Ile peptide, we were then able to model other SH2 domains and rationalize why they bound distinct peptide motifs. These analyses revealed critical residues in the SH2 domains that were likely to be responsible for determining peptide binding specificities. More importantly, once such mutations were generated, the binding specificity of the mutant SH2 domain could be quickly reevaluated with our oriented peptide library approach. For example, in a collaboration with Tony Pawson's group, we showed that a single mutation of the Src-SH2 domain could switch its binding specificity to resemble that of Sem5/ Grb-2 (Marengere et al., 1994) . As a result, the mutant Src SH2 domain could replace that of SEM-5 in a physiological setting.
Looking back, it may be possible to reclassify the global approach of determining the binding specifities of all SH2 domain as one of the prototypic proteomic studies, (although the word proteomic had yet to be coined). Incorporating the oriented peptide library data and structural modeling, coupled with the then rapidly expanding databases, we were able to predict a number of potential in vivo targets of SH2 domains. This work also paved way for oriented peptide analyses of protein kinase specificities and other protein-protein interaction modules such as PTB, PDZ, 14-3-3, and FHA domains (Durocher et al., 2000; Songyang et al., 1995b Songyang et al., , 1996 Songyang et al., , 1997 Yaffe et al., 1997) . The quantitative amino acid selectivity data produced by these approaches form the matrices that are the basis of the Scansite program (Yaffe et al., 2001 ). This program searches protein sequences for a key residue (e.g., Tyr) that is required for binding to a domain of interest and then scores the immediately surrounding sequence on the basis of how strongly the observed amino acid is selected at the same position (in relation to the key residue) in the oriented peptide library experiment. Unlike traditional pattern search algorithms such as ScanProsite, each of the matched sequences is given an absolute score and a percentile score compared to all other sites in all proteins in the public database. In the case of SH2 domains, because the specificities of protein tyrosine kinases have also been examined by peptide libraries (Songyang et al., 1995a) , it is now possible to predict not only whether a Tyr residue in a protein is likely to bind an SH2 domain but also whether the Tyr is likely to be phosphorylated by any of the protein-Tyr kinases that have been evaluated. (Yaffe et al., 2001 ). These candidate targets ultimately can be evaluated by mutation of the predicted tyrosine residues.
Perspective
New technologies and improved high-throughput methods mean that improvements of this "10 year old" technique are likely to blossom in the future. Traditional mass-spec approaches, which lack the quantification of the Edman approach and the ability to extract consensus information from simultaneous sequencing of billions of peptides, have not been very useful in deconvoluting results from soluble peptide library experiments. However, improvements in sensitivity, speed, quantitation, and software may solve this problem. In addition, oriented peptide libraries can be spotted on arrays to eliminate the need for peptide sequencing (Z.S., unpublished data). The array approach could also be taken one step further by printing all the possible peptide motifs in the genome as arrays. All of these methods are made more powerful because of the complete sequencing of the human genome and other genomes. Database predictions can be narrowed by evaluating the conservation of motifs through evolution. Ultimately, this approach may allow us to "read" the function of motifs and domains in proteins from linear sequences in a fashion analogous to deciphering words and paragraphs in ancient and forgotten scripts.
